EC
ABUS icon

EcoR1 Capital’s Arbutus Biopharma ABUS Stock Holding History

EcoR1 Capital’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,172,883
Closed -$7.78M – 40
2019
Q1 		$7.78M Sell
2,172,883
-1,108,619
-34% -$4.26M 0.72% 32
2018
Q4 		$12.6M Buy
3,281,502
+2,049,702
+166% +$10.1M 1.26% 25
2018
Q3 		$11.6M Buy
+1,231,800
New +$12.2M 1.05% 26

Other funds holding ABUS

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

EcoR1 Capital's ABUS Position: Q2 2019 in Review

EcoR1 Capital sold out of Arbutus Biopharma (ABUS) in Q2 2019, closing a stake of 2,172,883 shares — an estimated $7.78M sold.

EcoR1 Capital first reported a position in ABUS in Q3 2018 and held it in 3 quarters. The position peaked at $12.6M in Q4 2018. 62 funds tracked by Wall St. Rank hold ABUS as of Q2 2019.

  • EcoR1 Capital reported no remaining Arbutus Biopharma position as of Q2 2019 after selling out during the quarter.
  • EcoR1 Capital sold 2,172,883 Arbutus Biopharma shares in Q2 2019, an estimated $7.78M.
  • EcoR1 Capital first reported a position in Arbutus Biopharma in Q3 2018 and held it in 3 quarters.
  • EcoR1 Capital's Arbutus Biopharma position peaked at $12.6M in Q4 2018.
  • 62 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2019.

Based on EcoR1 Capital's 13F filing for Q2 2019, filed 14 Aug 2019.